Daewoong rekindling strategic alliance flame

Published: 2008-05-15 06:57:00

Updated: 2008-05-15 06:57:00

Daewoong Pharm is actively seeking strategic alliances with a number of multinational pharmaceutical firms using its strong sales and marketing force.

Daewoong and MSD Korea have recently agreed to jointly market Januvia (sitagliptin phosphate) under their second strategic alliance following F...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK